- Home
- ZURA vs CRUS Comparison
ZURA vs CRUS Comparison
Compare ZURA & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | CRUS |
|---|---|---|
| Founded | 2022 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 5.9B |
| IPO Year | N/A | 1989 |
Fundamental Metrics
Financial Performance| Metric | ZURA | CRUS |
|---|---|---|
| Price | $3.99 | $122.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $11.38 | ★ $140.00 |
| AVG Volume (30 Days) | 359.5K | ★ 482.1K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.23 |
| EPS | N/A | ★ 7.02 |
| Revenue | N/A | ★ $1,948,426,000.00 |
| Revenue This Year | N/A | $0.95 |
| Revenue Next Year | N/A | $1.88 |
| P/E Ratio | ★ N/A | $17.44 |
| Revenue Growth | N/A | ★ 2.19 |
| 52 Week Low | $0.97 | $75.83 |
| 52 Week High | $4.68 | $136.92 |
Technical Indicators
Market Signals| Indicator | ZURA | CRUS |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 50.66 |
| Support Level | $3.58 | $121.94 |
| Resistance Level | $3.94 | $127.01 |
| Average True Range (ATR) | 0.24 | 2.79 |
| MACD | 0.01 | 0.78 |
| Stochastic Oscillator | 95.69 | 58.67 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About CRUS Cirrus Logic Inc.
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.